Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : Validea

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Utah Medical Products Inc Reaffirms FY 2013 Guidance

Thursday, 24 Oct 2013 09:00am EDT 

Utah Medical Products Inc announced that for fiscal 2013, it expects revenues and net income to decline about 2%, and gross profit, operating income, EBT and EPS to be down about 3% compared to fiscal 2012. The Company reported EPS of $2.74 in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $2.73 for fiscal 2013. 

Company Quote

0.01 +0.02%
13 Oct 2015